SanDisk Corporation (NASDAQ:SNDK) climbed 7.78% to $77.
Kite Pharma Inc (NASDAQ:KITE), a clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy (eACT™) products for the treatment of cancer, today …
Maxim’s healthcare analysts are weighing in on the Boston drug company Keryx Biopharmaceuticals (NASDAQ:KERX) and cancer drug discovery company Kite Pharma Inc (NASDAQ:KITE), following recent announcements. Keryx Biopharmaceuticals In a …
Kite Pharma Inc (NASDAQ:KITE) announced that Steven A. Rosenberg, M.
Maxim analyst Jason McCarthy was out pounding the table on Kite Pharma Inc (NASDAQ:KITE) Thursday, reiterating a Buy rating and a price target of $87, which implies …
Kite Pharma, Inc. (NASDAQ:KITE) announced that Dr.
Kite Pharma Inc (NASDAQ:KITE) announced that it has expanded its collaboration with theNetherlands Cancer Institute (NKI). Kite and the NKI have entered into an …
Kite Pharma Inc (NASDAQ:KITE) announced that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) has adopted a positive opinion recommending KTE-C19 …
In a research report released today, FBR Capital analyst Edward White initiated coverage on shares of Kite Pharma Inc (NASDAQ:KITE) with a price target of …
